"Rosolov\u00E1, Hana" . . "Cor et Vasa" . . "288069" . "Rezidu\u00E1ln\u00ED vaskul\u00E1rn\u00ED riziko p\u0159etrv\u00E1v\u00E1 i p\u0159i l\u00E9\u010Db\u011B standardn\u00EDch rizikov\u00FDch faktor\u016F (hypertenze, kou\u0159en\u00ED, cholesterol). Je t\u0159eba vyu\u017E\u00EDt dal\u0161\u00ED biomarkery k up\u0159esn\u011Bn\u00ED rizika a soust\u0159edit se na l\u00E9\u010Dbu dal\u0161\u00EDch nov\u011Bj\u0161\u00EDch rizikov\u00FDch faktor\u016F." . "1"^^ . "[B062B1249D02]" . . "Sn\u00ED\u017Een\u00ED rezidu\u00E1ln\u00EDho vaskul\u00E1rn\u00EDho rizika bude hlavn\u00ED c\u00EDl preventivn\u00ED kardiologie 21. stolet\u00ED"@cs . . "Sn\u00ED\u017Een\u00ED rezidu\u00E1ln\u00EDho vaskul\u00E1rn\u00EDho rizika bude hlavn\u00ED c\u00EDl preventivn\u00ED kardiologie 21. stolet\u00ED"@cs . . "Rezidu\u00E1ln\u00ED vaskul\u00E1rn\u00ED riziko p\u0159etrv\u00E1v\u00E1 i p\u0159i l\u00E9\u010Db\u011B standardn\u00EDch rizikov\u00FDch faktor\u016F (hypertenze, kou\u0159en\u00ED, cholesterol). Je t\u0159eba vyu\u017E\u00EDt dal\u0161\u00ED biomarkery k up\u0159esn\u011Bn\u00ED rizika a soust\u0159edit se na l\u00E9\u010Dbu dal\u0161\u00EDch nov\u011Bj\u0161\u00EDch rizikov\u00FDch faktor\u016F."@cs . . . "CZ - \u010Cesk\u00E1 republika" . "Reduction of residual vascular risk will be a big challenge of preventive cardiology in the 21-st century"@en . . "RIV/00669806:_____/10:00300864!RIV11-MZ0-00669806" . "52" . . "0010-8650" . "Reduction of residual vascular risk will be a big challenge of preventive cardiology in the 21-st century"@en . "1"^^ . "Sn\u00ED\u017Een\u00ED rezidu\u00E1ln\u00EDho vaskul\u00E1rn\u00EDho rizika bude hlavn\u00ED c\u00EDl preventivn\u00ED kardiologie 21. stolet\u00ED" . "RIV/00669806:_____/10:00300864" . "Sn\u00ED\u017Een\u00ED rezidu\u00E1ln\u00EDho vaskul\u00E1rn\u00EDho rizika bude hlavn\u00ED c\u00EDl preventivn\u00ED kardiologie 21. stolet\u00ED" . . . "4" . . "residual vascular risk"@en . "Residual vascular risk persisted after the therapy of standard risk factors (hypertension, cholesterol and smoking). It is necessary to use other biomarkers for better risk stratification and to focuse on the management of alarming risk factors."@en . "3"^^ . "V" .